CD19-TriCAR-T/SILK
2018-127
Phase 1 mab active
Quick answer
CD19-TriCAR-T/SILK for Non-Hodgkin Lymphoma is a Phase 1 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Non-Hodgkin Lymphoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active